Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

Illumina Inc (ILMN.O), the top maker of DNA sequencers used to speed drug development and other research, on Thursday announced the launch of its next-generation NovaSeq X systems, which it said can generate more than 20,000 whole genomes per year, or 2.5 times that of prior sequencers.

On 29 September, Suzhou Novoprotein Scientific Co., Ltd. was listed on the STAR Market. The stock name is Novoprotein, the stock code is 688137. SH, with the issue price is 106.19 CNY / share, which broke after the opening, with a market capitalization of over CNY 5.6 billion.

OraSure Technologies announced on Wednesday that it has been awarded an $8.6 million contract from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA).

Becton Dickinson and CerTest Biotec have made a PCR assay for monkeypox virus available commercially in the U.S. and other markets worldwide.

Recently, the TSure Nucleic Acid Analysis Device independently developed by Sansure obtained CE mark, which will further meet and expand the global testing market demands at all levels, and serve the construction of public health prevention and control system in every country better.s

Thermo Fisher Scientific said on Tuesday that its next-generation sequencing-based Oncomine Dx Target Test has been approved by the US FDA as a companion diagnostic (CDx) to identify patients with advanced RET-driven lung and thyroid cancers who may be eligible for Lilly’s Retevmo (selpercatinib).

In order to align with Shanghai's goal of accelerating the construction of a scientific and technological innovation center, a high-level research institution dedicated to virology source innovation and clinical translation will be built in Shanghai.

The US Food and Drug Administration said on Tuesday that it is updating its policy on Emergency Use Authorizations for COVID-19 tests and limiting its review of new submissions.

The UK's National Institute for Health and Clinical Excellence has created a new program to evaluate innovative technologies and plans to assess Genedrive's MT-RNR1 test for antibiotics-induced hearing loss in infants via this new process, the company said on Monday.

BioIVT, a provider of research models and services for drug discovery and development, said on Monday that it has acquired Bulgarian biospecimen firm Fidelis Research.